The successful deployment of mRNA vaccines against COVID-19 and their potential to prevent other infections and diseases has prompted the European Pharmacopoeia (PhEur) Commission to establish a new working party to help support this emerging field.
Quality standards developed by the new mRNA vaccines (mRNAVAC) working party will be included in the PhEur, said the European...







